Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,478
archived clinical trials in
Smoking Cessation

A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Meridien Research
mi
from
Tampa, FL
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Meridien Research
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
iResearch Atlanta LLC
mi
from
Decatur, GA
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
iResearch Atlanta LLC
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Quality Clinical Research, Inc.
mi
from
Omaha, NE
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Quality Clinical Research, Inc.
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Clinical Research Center of Nevada, LLC
mi
from
Las Vegas, NV
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Clinical Research Center of Nevada, LLC
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Integrative Clinical Trials, LLC
mi
from
Brooklyn, NY
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Integrative Clinical Trials, LLC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Duke University
mi
from
Durham, NC
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
PMG Research
mi
from
Raleigh, NC
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
PMG Research
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
PMG Research Inc.
mi
from
Wilimington, NC
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
PMG Research Inc.
mi
from
Wilimington, NC
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
PMG Research Inc.
mi
from
Winston-Salem, NC
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
PMG Research Inc.
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Neurobehavioral Clinical Research
mi
from
Canton, OH
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Neurobehavioral Clinical Research
mi
from
Canton, OH
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Midwest Clinical Research Center
mi
from
Dayton, OH
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
The Clinical Trial Center, LLC
mi
from
Jenkintown, PA
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
The Clinical Trial Center, LLC
mi
from
Jenkintown, PA
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Lincoln Research
mi
from
Lincoln, RI
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Lincoln Research
mi
from
Lincoln, RI
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Coastal Carolina Research Center
mi
from
Mt. Pleasant, SC
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Coastal Carolina Research Center
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Clinical Research Associates
mi
from
Nashville, TN
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Clinical Research Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Benchmark Research
mi
from
Austin, TX
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Benchmark Research
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
KRK Medical Research
mi
from
Dallas, TX
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
KRK Medical Research
mi
from
Dallas, TX
Click here to add this to my saved trials
"Quit Smoking on Your Own" Brief Online Study
"Quit Smoking on Your Own" Brief Online Study
Status: Enrolling
Updated:  5/21/2015
Palo Alto University i4Health
mi
from
Palo Alto, CA
"Quit Smoking on Your Own" Brief Online Study
"Quit Smoking on Your Own" Brief Online Study
Status: Enrolling
Updated: 5/21/2015
Palo Alto University i4Health
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients
Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients.
Status: Enrolling
Updated:  7/1/2015
Bellevue Hospital Center
mi
from
New York, NY
Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients
Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients.
Status: Enrolling
Updated: 7/1/2015
Bellevue Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients
Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients.
Status: Enrolling
Updated:  7/1/2015
Va New York Harbor Healthcare System
mi
from
New York, NY
Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients
Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients.
Status: Enrolling
Updated: 7/1/2015
Va New York Harbor Healthcare System
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Status: Enrolling
Updated:  7/1/2015
Duke Center for Smoking Cessation
mi
from
Charlotte, NC
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Status: Enrolling
Updated: 7/1/2015
Duke Center for Smoking Cessation
mi
from
Charlotte, NC
Click here to add this to my saved trials
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Status: Enrolling
Updated:  7/1/2015
Duke Center forSmoking Cessation
mi
from
Durham, NC
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Status: Enrolling
Updated: 7/1/2015
Duke Center forSmoking Cessation
mi
from
Durham, NC
Click here to add this to my saved trials
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Status: Enrolling
Updated:  7/1/2015
Duke Center for Smoking Cessation
mi
from
Winston-Salem, NC
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Status: Enrolling
Updated: 7/1/2015
Duke Center for Smoking Cessation
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
GABA (Gamma Amino Butyric Acid) Medication for Tobacco
Pregabalin Given to Tobacco Users to Study Addiction
Status: Enrolling
Updated:  7/7/2015
Yale University
mi
from
New Haven, CT
GABA (Gamma Amino Butyric Acid) Medication for Tobacco
Pregabalin Given to Tobacco Users to Study Addiction
Status: Enrolling
Updated: 7/7/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Patient Experience Recommender System for Persuasive Communication Tailoring
PERSPECT: Patient Experience Recommender System for Persuasive Communication Tailoring
Status: Enrolling
Updated:  7/7/2015
Univ of Massachusetts Med School
mi
from
Worcester, MA
Patient Experience Recommender System for Persuasive Communication Tailoring
PERSPECT: Patient Experience Recommender System for Persuasive Communication Tailoring
Status: Enrolling
Updated: 7/7/2015
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
Galantamine Effects on Nicotine Responses in Smokers
Galantamine Effects on Nicotine Responses in Smokers
Status: Enrolling
Updated:  7/7/2015
Department of Veterans Affairs
mi
from
West Haven, CT
Galantamine Effects on Nicotine Responses in Smokers
Galantamine Effects on Nicotine Responses in Smokers
Status: Enrolling
Updated: 7/7/2015
Department of Veterans Affairs
mi
from
West Haven, CT
Click here to add this to my saved trials
Culturally Specific Interventions: African American Smokers
Culturally Specific Interventions and Acculturation in African American Smokers
Status: Enrolling
Updated:  7/9/2015
University of Miami
mi
from
Coral Gables, FL
Culturally Specific Interventions: African American Smokers
Culturally Specific Interventions and Acculturation in African American Smokers
Status: Enrolling
Updated: 7/9/2015
University of Miami
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Effects of Transcranial Direct Current Stimulation on Tobacco Withdrawal Symptoms
Phase 1 Study of Effects of tDCS on Tobacco Withdrawal Symptoms
Status: Enrolling
Updated:  7/14/2015
1 Church Street, Room 729
mi
from
New Haven, CT
Effects of Transcranial Direct Current Stimulation on Tobacco Withdrawal Symptoms
Phase 1 Study of Effects of tDCS on Tobacco Withdrawal Symptoms
Status: Enrolling
Updated: 7/14/2015
1 Church Street, Room 729
mi
from
New Haven, CT
Click here to add this to my saved trials
Mood and Anti-craving Effects of Varenicline in Psychiatric Inpatients
Assessment of Response to Open-label Treatment With Varenicline in Psychiatric Inpatients
Status: Enrolling
Updated:  7/20/2015
Butler Hospital
mi
from
Providence, RI
Mood and Anti-craving Effects of Varenicline in Psychiatric Inpatients
Assessment of Response to Open-label Treatment With Varenicline in Psychiatric Inpatients
Status: Enrolling
Updated: 7/20/2015
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)
D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation
Status: Enrolling
Updated:  7/20/2015
Boston University
mi
from
Boston, MA
D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)
D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation
Status: Enrolling
Updated: 7/20/2015
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit
Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit
Status: Enrolling
Updated:  7/22/2015
Division of Addiction Psychiatry
mi
from
New Brunswick, NJ
Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit
Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit
Status: Enrolling
Updated: 7/22/2015
Division of Addiction Psychiatry
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1
Smoking, Antidepressants, and Response to Mental Stress
Status: Enrolling
Updated:  7/28/2015
College of Pharmacy
mi
from
Minneapolis, MN
Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1
Smoking, Antidepressants, and Response to Mental Stress
Status: Enrolling
Updated: 7/28/2015
College of Pharmacy
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Smoking Cessation for Veterans With Severe and Persistent Mental Illness
Randomized Trial of a Smoking Cessation Program for Persons With SMI
Status: Enrolling
Updated:  7/28/2015
Washington DC VA Medical Center, Washington, DC
mi
from
Washington,
Smoking Cessation for Veterans With Severe and Persistent Mental Illness
Randomized Trial of a Smoking Cessation Program for Persons With SMI
Status: Enrolling
Updated: 7/28/2015
Washington DC VA Medical Center, Washington, DC
mi
from
Washington,
Click here to add this to my saved trials
Smoking Cessation for Veterans With Severe and Persistent Mental Illness
Randomized Trial of a Smoking Cessation Program for Persons With SMI
Status: Enrolling
Updated:  7/28/2015
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Smoking Cessation for Veterans With Severe and Persistent Mental Illness
Randomized Trial of a Smoking Cessation Program for Persons With SMI
Status: Enrolling
Updated: 7/28/2015
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice
Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice
Status: Enrolling
Updated:  7/28/2015
Staten Island University Hospital
mi
from
Staten Island, NY
Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice
Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice
Status: Enrolling
Updated: 7/28/2015
Staten Island University Hospital
mi
from
Staten Island, NY
Click here to add this to my saved trials
Women Engaging in Quitting Smoking Together (WE QUIT)
Distress Tolerance Treatment for Weight Concern in Smoking Cessation Among Women
Status: Enrolling
Updated:  7/30/2015
Butler Hospital
mi
from
Providence, RI
Women Engaging in Quitting Smoking Together (WE QUIT)
Distress Tolerance Treatment for Weight Concern in Smoking Cessation Among Women
Status: Enrolling
Updated: 7/30/2015
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Phase IIA Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Status: Enrolling
Updated:  7/30/2015
Chao Family Comprehensive Cancer Center
mi
from
Orange, CA
Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Phase IIA Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Status: Enrolling
Updated: 7/30/2015
Chao Family Comprehensive Cancer Center
mi
from
Orange, CA
Click here to add this to my saved trials
Tobacco Quit Line Re-enrollments for the Underserved
Re-engagement in Evidence-based Quit Line Treatment for Low Income Smokers
Status: Enrolling
Updated:  8/10/2015
Free & Clear, Inc.
mi
from
Seattle, WA
Tobacco Quit Line Re-enrollments for the Underserved
Re-engagement in Evidence-based Quit Line Treatment for Low Income Smokers
Status: Enrolling
Updated: 8/10/2015
Free & Clear, Inc.
mi
from
Seattle, WA
Click here to add this to my saved trials
An Alternative Dosing Schedule of Varenicline for Smoking Cessation
Extended Varenicline for Smoking Cessation: A Pilot Study
Status: Enrolling
Updated:  8/11/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
An Alternative Dosing Schedule of Varenicline for Smoking Cessation
Extended Varenicline for Smoking Cessation: A Pilot Study
Status: Enrolling
Updated: 8/11/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers
Study 1: Preference, Health Effects and Efficacy of Four Oral Tobacco Products for Smoking Cessation
Status: Enrolling
Updated:  8/14/2015
Univeristy of Minnesota
mi
from
Minneapolis, MN
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers
Study 1: Preference, Health Effects and Efficacy of Four Oral Tobacco Products for Smoking Cessation
Status: Enrolling
Updated: 8/14/2015
Univeristy of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers
Study 1: Preference, Health Effects and Efficacy of Four Oral Tobacco Products for Smoking Cessation
Status: Enrolling
Updated:  8/14/2015
Oregon Research Institute
mi
from
Eugene, OR
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers
Study 1: Preference, Health Effects and Efficacy of Four Oral Tobacco Products for Smoking Cessation
Status: Enrolling
Updated: 8/14/2015
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Persistence-Targeted Smoking Cessation
Persistence-Targeted Smoking Cessation
Status: Enrolling
Updated:  8/17/2015
Rutgers Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Persistence-Targeted Smoking Cessation
Persistence-Targeted Smoking Cessation
Status: Enrolling
Updated: 8/17/2015
Rutgers Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
Status: Enrolling
Updated:  8/17/2015
Abel Buchheim Pharmaceutical Research
mi
from
Miami, FL
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
Status: Enrolling
Updated: 8/17/2015
Abel Buchheim Pharmaceutical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
Status: Enrolling
Updated:  8/17/2015
Hope Research Center
mi
from
Phoenix, AZ
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
Status: Enrolling
Updated: 8/17/2015
Hope Research Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
Status: Enrolling
Updated:  8/17/2015
Nuren Medical
mi
from
Miami, FL
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
Status: Enrolling
Updated: 8/17/2015
Nuren Medical
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
Status: Enrolling
Updated:  8/17/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction
Status: Enrolling
Updated: 8/17/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Assessment of a Teachable Moment for Smoking Cessation
Assessment of a Teachable Moment for Smoking Cessation
Status: Enrolling
Updated:  8/20/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Assessment of a Teachable Moment for Smoking Cessation
Assessment of a Teachable Moment for Smoking Cessation
Status: Enrolling
Updated: 8/20/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers
Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers
Status: Enrolling
Updated:  8/27/2015
Yale University School of Medicine
mi
from
New Haven, CT
Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers
Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers
Status: Enrolling
Updated: 8/27/2015
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials